Dialysis Market by Product (Haemodialysis [Dialyzers, Bloodlines, Dialysates {Alkaline, Acidic}, CVC, AV Fistula, AV Graft] Peritoneal Dialysis [Conventional, Nocturnal]), End User (Hospital, Homecare, Dialysis Center) - Global Forecast to 2031

The Dialysis Market was valued at $20.26  billion in 2023. This market is expected to reach $36.6  billion by 2031, from an estimated $21.92  billion in 2024, at a CAGR of 7.6% during the forecast period 2024-2031.

Dialysis Market Size & Forecast

Hemodialysis is a treatment for kidney failure patients in which wastes, salts, and fluid are removed from a patient's blood. In peritoneal dialysis, the abdominal cavity's peritoneum cleans the kidney. Dialysis machines, dialyzers, bloodlines, catheters, and dialysates are required to carry out the dialysis treatment.

The introduction of IoT in Remote Dialysis Management is the Prevailing Trend in the Market

The adoption of the Internet of Things (IoT) for in-home care & long-term care centers has grown significantly in recent years. IoT devices have the ability to change healthcare by improving patient care, delivering real-time monitoring, and boosting productivity. The trend of independent living among the elderly and the growing geriatric population, along with kidney disorders, has increased the demand for IoT-enabled remote dialysis care and devices, especially for in-home care. IoT-enabled dialysis devices assist healthcare providers by offering preventive care, remote monitoring, and immediate treatments. Additionally, an estimated 2 million patients worldwide are affected by kidney failure. (Source: The Kidney Project, The Regents of the University of California Report). Such instances are expected to boost the demand for IoT in remote dialysis management.

The growth of this market is driven by the growing prevalence of kidney disorders, diabetes, and hypertension, the increasing number of dialysis centers, initiatives for chronic kidney care, shortage & side effects of kidney transplants, and the rising prevalence of early-stage renal disease. Additionally, technological advancements in dialysis machines, rising preference for home dialysis, and emerging economies are expected to offer significant market growth opportunities.

However, reimbursement issues in emerging economies and stringent regulatory policies for the approval and manufacturing of dialysis products restrain the growth of this market. Additionally, the rise in complications related to dialysis treatment, the high number of product recalls, and the high maintenance of hemodialysis equipment for small hospitals and ambulatory centers pose a significant challenge to the market's growth.

Initiatives for Chronic Kidney Care is Driving the Market’s Growth

As chronic kidney disorders are increasing, various initiatives are taken by organizations to support dialysis treatment for patients. Some of these include:

• The European Kidney Health Alliance (EKHA), a non-governmental organization based in Brussels, Belgium, focuses on advocating for kidney patients and the nephrology community at relevant EU and European national organizations. In 2021, the EKHA will focus on reimbursement strategies and access to KRT, especially home hemodialysis.
• In 2020, the Strategic National Stockpile, managed by HHS’s Assistant Secretary for Preparedness and Response (ASPR), deployed new dialysis technology through an HHS contract with Outset Medical. The machine uses tap water to make the solution necessary for dialysis on demand, reducing the demand for dialysis supplies. ASPR is also in the process of acquiring more units.
• In India, peritoneal dialysis is included in the Pradhan Mantri National Dialysis Program to reduce the out-of-pocket expenditure of the patients undergoing dialysis.
• SHAREHD is a shared hemodialysis (HD) care program led by Sheffield Teaching Hospital NHS Foundation Trust that supports people in self-managing their dialysis elements.
• BC Provincial Renal Agency (BCPRA) has formed various committees to support dialysis. The BCPRA Peritoneal Dialysis (PD) Committee provides peritoneal dialysis care and ensures the appropriate delivery of services through provincial contracts. The BCPRA Hemodialysis Committee works to improve HD care across BC by developing provincial standards & tools and supporting system changes. The BCPRA Home Hemodialysis Committee provides direction to the provincially coordinated, locally delivered independent hemodialysis program, including home hemodialysis and self-care hemodialysis within facilities.

Such initiatives are expected to drive the global dialysis market in the long run.

Click here to: Get Free Sample Pages of this Report

Technological Advancements in Dialysis Machines to Offer Market Growth Opportunities

Dialysis machines with advanced technologies are designed to improve patient care, optimize treatment delivery, and reduce care variations. Enhancements have been attributed to hemodialysis technology's many subsections, such as membrane materials, membrane configurations, pore size distributions, and cut-off & membrane modalities. In 2019, the Innovations in Dialysis—Expediting Advances Symposium (IDEAS) Conference was held to bring together innovators of wearable, portable, and implantable dialysis technologies, including researchers, entrepreneurs, physicians, patients, industry representatives, and government officials committed to improving the outcomes and reducing cost for people with ESKD.

In response to the need for cost-effective dialysis options, in November 2022, the American Kidney Fund, Inc., launched the Patient Access Initiative, a new effort to address ongoing healthcare access issues faced by patients with kidney disease, including rare kidney disease.

In addition, the need for more highly refined methods of creating a more quickly accessible permanent vascular access and the opportunity to develop assistance in cannulation and removal of needles will enhance the reliability of the dialysis procedure. Various companies are focusing on various organic and inorganic strategies to enhance their presence in this market. Some of these are mentioned below:

• In February 2024, Fresenius Medical Care (FME) (U.S.) received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 5008X Hemodialysis System. The company estimates that a 5008X hemodiafiltration system can replace around 160,000 standard hemodialysis machines that are currently operating in the dialysis centers of the country.
• In April 2023, Medtronic plc (U.S.) and DaVita Inc. (U.S.) launched Mozarc Medical (U.S.), a company focusing on kidney healthcare and driving patient-centered technology solutions that will enhance overall patient care and increase access to kidney healthcare globally.

New dialysis modalities, combining medium cut-off membranes and internal filtration to enhance clearance of middle and large molecular compounds, are currently being explored. Tailoring the electrolyte prescription and dialysate composition to the patient's current condition further aims to improve dialysis by 2030.

Studies have shown that survival in end-stage renal disease and overall health are better with home dialysis. There have been advances in in-home dialysis technologies that have simplified hemodialysis, allowing it to be performed in the comfort of a patient’s home. The advanced, smaller dialysis machines and more uncomplicated blood tubing make it easier to manage. The treatment can be done in the patient’s free time by having short daily sessions or a more extended session at night. Other advantages of home hemodialysis are gentle fluid removal and better phosphorous control. Thus, technological advancements in dialysis machines are expected to boost the dialysis market.

Key Findings in the Dialysis Market Study:

Among the Hemodialysis Products, the Consumables Segment is Expected to Account for the Largest Share of the Market in 2024

Among the hemodialysis products, in 2024, the consumables segment is expected to account for the largest share of the hemodialysis market. The largest share of the segment is attributed to the increasing number of patients with chronic kidney disease (CKD), or kidney failure, the rising demand for hemodialysis consumables at home and dialysis centers, and government initiatives such as Medicare (U.S.), which covers up to 80% cost of home hemodialysis.

Among the Peritoneal Dialysis Products, the Dialysate Segment is Expected to Account for the Largest Share of the Market in 2024

Among the peritoneal dialysis products, in 2024, the peritoneal dialysis dialysate segment is expected to account for the largest share of the peritoneal dialysis market. The need for dialysate solutions at every stage of peritoneal dialysis, high demand for dialysate solutions, and increasing demand for peritoneal dialysis due to its advantages are contributing to the large share of the segment.

Among the Types, the Conventional Segment is Expected to Account for the Largest Share of the Market in 2024

Among the types, in 2024, the conventional segment is expected to account for the largest share of the hemodialysis market. Conventional hemodialysis offers the benefits of home therapy with regard to patient power and flexibility. Limiting treatment to three times per week helps reduce the patient and caregiver treatment burden. Additionally, patients' high preference for conventional hemodialysis is among the major factors leading to the large share of the segment.

Among the End Users, the Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024

Among the end users, in 2024, the hospitals segment is expected to account for the largest share of the dialysis market. From 2010 to 2030, due to the increased risk of chronic diseases such as hypertension and diabetes, the prevalence of kidney failure is expected to double. With this prevalence, the need for renal replacement therapy is also expected to increase. Renal replacement therapy can be achieved through different types of dialysis and kidney transplants. The choice of kidney transplants is limited due to its complexity, cost, and donor availability. Therefore, dialysis remains the choice to consider as support treatment. Therefore, hospitals are highly preferred by patients for their treatment, which is expected to support the large share of the segment.

Among the Disease Indications, the End Stage Kidney Disease (ESKD) Segment is Expected to Account for the Largest Share of the Market in 2024

Among the disease indications, in 2024, the end stage kidney disease segment is expected to account for the largest share of the dialysis market. The increasing number of patients with diabetes, heart diseases, and urinary tract blockage leads to high possibilities of ESKD, and the increasing prevalence of ESKD and recurrent kidney infections are some of the major factors driving the growth of this segment.

Asia-Pacific: Fastest-growing Regional Market

Asia-Pacific is one of the fastest-growing markets for dialysis. Factors such as the increasing number of independent dialysis centers, increasing awareness about dialysis treatment modalities, and favorable government policies are propelling the demand for dialysis products in the region. However, affordability, access to treatment in rural areas, and the lack of skilled professionals are challenging the growth of this market.

Dialysis Market: Competitive Analysis

The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them in the last three to four years. The key players profiled in the dialysis market report are Becton, Dickinson and Company (BD) (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGAA (Germany), Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation) (Japan), Wego Healthcare (Shenzhen) Co. Ltd. (China), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (U.S.), Kawasumi Laboratories, Inc. (Japan), Nipro Corporation (Japan), Quanta Dialysis Technologies, Ltd. (U.S.), and Toray Industries, Inc. (Japan).

Dialysis Market Report Summary:

Key questions answered in the report: